Cost effectiveness of Vericiguat for the treatment of chronic heart failure with reduced ejection fraction following a worsening heart failure event from a US Medicare perspective
Authors: Alsumali, A., Djatche, L.M., Briggs, A., Liu, R., Diakite, I., Patel, D., Wang, Y. and Lautsch, D.